Evidence map›Paper›PMID 37111165›Full record

ReviewNutrients2023

Structures, Sources, Identification/Quantification Methods, Health Benefits, Bioaccessibility, and Products of Isorhamnetin Glycosides as Phytonutrients.

Hong Wang, Lijia Chen, Binrui Yang, Jun Du, Liang Chen, Yiming Li, Fujiang Guo

Abstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Polyphenols in Litchi (Food science & nutrition · 2026
    Article
  3. Antioxidant Activity of EthanolicMolecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Identification of Metabolites and Antioxidant Constituents fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Frontiers in pharmacology · 2025
    Article
  20. Molecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hong WangSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Lijia ChenSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Binrui YangNutrition Science, Amway (Shanghai) Innovation & Science Co., Ltd., Shanghai 201203, China.
Jun DuNutrition Science, Amway (Shanghai) Innovation & Science Co., Ltd., Shanghai 201203, China.
Liang ChenNutrition Science, Amway (Shanghai) Innovation & Science Co., Ltd., Shanghai 201203, China.ORCID 0000-0001-7434-4461
Yiming LiSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.ORCID 0000-0003-3416-1331
Fujiang GuoSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.ORCID 0000-0003-4073-4773

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, people have tended to consume phytonutrients and nutrients in their daily diets. Isorhamnetin glycosides (IGs) are an essential class of flavonoids derived from dietary and medicinal plants such as

Indexed as

GlycosidesQuercetinFlavonoidsHumansPhytochemicalsPlant Extracts3-methylquercetinFlavonoidsGlycosidesPhytochemicalsPlant ExtractsQuercetinhealth-promoting effectsisorhamnetin glycosidesphytonutrientssources

Identifiers

PMID37111165
PMCPMC10143801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.